![](/img/cover-not-exists.png)
(945): Effect of alvimopan, a peripheral opioid receptor antagonist, on health-related quality of life (HRQOL) in patients who develop gastrointestinal adverse events (GIAEs) while taking opioids for persistent-non-cancer pain
M. Tark, R. Sabatowski, L. Frank, A. Rentz, C. Kleoudis, T. BellVolume:
7
Year:
2006
Language:
english
DOI:
10.1016/j.jpain.2006.01.347
File:
PDF, 45 KB
english, 2006